These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 23751397

  • 1. Isolated active ileitis: is it a mild subtype of Crohn's disease?
    O'Donnell S, Crotty PL, O'Sullivan M, Breslin N, O'Connor HJ, O'Morain CA, Ryan BM.
    Inflamm Bowel Dis; 2013 Aug; 19(9):1815-22. PubMed ID: 23751397
    [Abstract] [Full Text] [Related]

  • 2. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
    Papp M, Altorjay I, Dotan N, Palatka K, Foldi I, Tumpek J, Sipka S, Udvardy M, Dinya T, Lakatos L, Kovacs A, Molnar T, Tulassay Z, Miheller P, Norman GL, Szamosi T, Papp J, Hungarian IBD Study Group, Lakatos PL.
    Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543
    [Abstract] [Full Text] [Related]

  • 3. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
    Zholudev A, Zurakowski D, Young W, Leichtner A, Bousvaros A.
    Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
    [Abstract] [Full Text] [Related]

  • 4. Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients.
    Papp M, Altorjay I, Norman GL, Shums Z, Palatka K, Vitalis Z, Foldi I, Lakos G, Tumpek J, Udvardy ML, Harsfalvi J, Fischer S, Lakatos L, Kovacs A, Bene L, Molnar T, Tulassay Z, Miheller P, Veres G, Papp J, Hungarian IBD Study Group, Lakatos PL.
    Inflamm Bowel Dis; 2007 Aug; 13(8):984-92. PubMed ID: 17417801
    [Abstract] [Full Text] [Related]

  • 5. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations.
    Walker LJ, Aldhous MC, Drummond HE, Smith BR, Nimmo ER, Arnott ID, Satsangi J.
    Clin Exp Immunol; 2004 Mar; 135(3):490-6. PubMed ID: 15008984
    [Abstract] [Full Text] [Related]

  • 6. Combining TNFSF15 and ASCA IgA can be used as a predictor for the stenosis/perforating phenotype of Crohn's disease.
    Tung CC, Wong JM, Lee WC, Liu HH, Chang CH, Chang MC, Chang YT, Shieh MJ, Wang CY, Wei SC.
    J Gastroenterol Hepatol; 2014 Apr; 29(4):723-9. PubMed ID: 24783249
    [Abstract] [Full Text] [Related]

  • 7. Phenotypic associations of Crohn's disease with antibodies to flagellins A4-Fla2 and Fla-X, ASCA, p-ANCA, PAB, and NOD2 mutations in a Swiss Cohort.
    Schoepfer AM, Schaffer T, Mueller S, Flogerzi B, Vassella E, Seibold-Schmid B, Seibold F.
    Inflamm Bowel Dis; 2009 Sep; 15(9):1358-67. PubMed ID: 19253375
    [Abstract] [Full Text] [Related]

  • 8. Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course.
    Paul S, Boschetti G, Rinaudo-Gaujous M, Moreau A, Del Tedesco E, Bonneau J, Presles E, Mounsef F, Clavel L, Genin C, Flourié B, Phelip JM, Nancey S, Roblin X.
    J Crohns Colitis; 2015 Jun; 9(6):445-51. PubMed ID: 25895876
    [Abstract] [Full Text] [Related]

  • 9. Concordance in Anti-OmpC and Anti-I2 Indicate the Influence of Genetic Predisposition: Results of a European Study of Twins with Crohn's Disease.
    Amcoff K, Joossens M, Pierik MJ, Jonkers D, Bohr J, Joossens S, Romberg-Camps M, Nyhlin N, Wickbom A, Rutgeerts PJ, Tysk C, Bodin L, Colombel JF, Vermeire S, Halfvarson J.
    J Crohns Colitis; 2016 Jun; 10(6):695-702. PubMed ID: 26818662
    [Abstract] [Full Text] [Related]

  • 10. Serological markers predict inflammatory bowel disease years before the diagnosis.
    van Schaik FD, Oldenburg B, Hart AR, Siersema PD, Lindgren S, Grip O, Teucher B, Kaaks R, Bergmann MM, Boeing H, Carbonnel F, Jantchou P, Boutron-Ruault MC, Tjønneland A, Olsen A, Crowe FL, Peeters PH, van Oijen MG, Bueno-de-Mesquita HB.
    Gut; 2013 May; 62(5):683-8. PubMed ID: 22842615
    [Abstract] [Full Text] [Related]

  • 11. Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease.
    Gologan S, Iacob R, Preda C, Vadan R, Cotruta B, Catuneanu AM, Iacob S, Constantinescu I, Gheorghe L, Iobagiu S, Gheorghe C, Diculescu M.
    J Gastrointestin Liver Dis; 2012 Mar; 21(1):39-44. PubMed ID: 22457858
    [Abstract] [Full Text] [Related]

  • 12. The clinical significance of antimicrobial serologic responses within an Irish Crohn's disease population.
    O'Donnell S, O'Sullivan M, O'Morain CA, Ryan BM.
    Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1464-9. PubMed ID: 24047859
    [Abstract] [Full Text] [Related]

  • 13. Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease.
    Forcione DG, Rosen MJ, Kisiel JB, Sands BE.
    Gut; 2004 Aug; 53(8):1117-22. PubMed ID: 15247177
    [Abstract] [Full Text] [Related]

  • 14. Antibodies to saccharomyces cerevisiae in Crohn's disease: higher titers are associated with a greater frequency of mutant NOD2/CARD15 alleles and with a higher probability of complicated disease.
    Dassopoulos T, Frangakis C, Cruz-Correa M, Talor MV, Burek CL, Datta L, Nouvet F, Bayless TM, Brant SR.
    Inflamm Bowel Dis; 2007 Feb; 13(2):143-51. PubMed ID: 17206688
    [Abstract] [Full Text] [Related]

  • 15. Serum antibodies associated with complex inflammatory bowel disease.
    Elkadri AA, Stempak JM, Walters TD, Lal S, Griffiths AM, Steinhart AH, Silverberg MS.
    Inflamm Bowel Dis; 2013 Jun; 19(7):1499-505. PubMed ID: 23702714
    [Abstract] [Full Text] [Related]

  • 16. Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease--an IG-IBD study.
    Annese V, Lombardi G, Perri F, D'Incà R, Ardizzone S, Riegler G, Giaccari S, Vecchi M, Castiglione F, Gionchetti P, Cocchiara E, Vigneri S, Latiano A, Palmieri O, Andriulli A.
    Am J Gastroenterol; 2005 Jan; 100(1):84-92. PubMed ID: 15654786
    [Abstract] [Full Text] [Related]

  • 17. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.
    Sipeki N, Davida L, Palyu E, Altorjay I, Harsfalvi J, Szalmas PA, Szabo Z, Veres G, Shums Z, Norman GL, Lakatos PL, Papp M.
    World J Gastroenterol; 2015 Jun 14; 21(22):6952-64. PubMed ID: 26078573
    [Abstract] [Full Text] [Related]

  • 18. Gene expression profiles of ileal inflammatory bowel disease correlate with disease phenotype and advance understanding of its immunopathogenesis.
    Ben-Shachar S, Yanai H, Baram L, Elad H, Meirovithz E, Ofer A, Brazowski E, Tulchinsky H, Pasmanik-Chor M, Dotan I.
    Inflamm Bowel Dis; 2013 Nov 14; 19(12):2509-21. PubMed ID: 24108111
    [Abstract] [Full Text] [Related]

  • 19. The value of serum antibodies in differentiating inflammatory bowel disease, predicting disease activity and disease course in the newly diagnosed patient.
    Smids C, Horjus Talabur Horje CS, Groenen MJM, van Koolwijk EHM, Wahab PJ, van Lochem EG.
    Scand J Gastroenterol; 2017 Oct 14; 52(10):1104-1112. PubMed ID: 28661185
    [Abstract] [Full Text] [Related]

  • 20. Low mannose-binding lectin (MBL) is associated with paediatric inflammatory bowel diseases and ileal involvement in patients with Crohn disease.
    Kovacs M, Papp M, Lakatos PL, Jacobsen S, Nemes E, Polgar M, Solyom E, Bodi P, Horvath A, Molnar K, Szabo D, Cseh A, Muller KE, Dezsofi A, Arato A, Veres G.
    J Crohns Colitis; 2013 Mar 14; 7(2):134-41. PubMed ID: 22504031
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.